PROTHENA CORPORATION PLC - ORDINARY SHARES

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

05 Apr 2024 08:45:33 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

04 Apr 2024 11:49:03 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

03 Apr 2024 08:45:03 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

02 Apr 2024 09:53:49 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

28 Mar 2024 09:42:06 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

05 Feb 2024 08:45:57 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

02 Feb 2024 08:45:02 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

01 Feb 2024 08:53:56 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

31 Jan 2024 15:00:38 By NetDania Notify

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

27 Oct 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena to Participate in Upcoming Healthcare Conferences

01 Sep 2022 15:20:00 By Nasdaq GlobeNewswire

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

01 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

08 Aug 2022 15:05:02 By Nasdaq GlobeNewswire

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena to Report Second Quarter 2022 Financial Results on August 8th

01 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Jul 2022 15:16:52 By Nasdaq GlobeNewswire

Prothena to Participate in Jefferies Healthcare Conference

02 Jun 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Reports First Quarter 2022 Financial Results and Business Highlights

05 May 2022 15:05:05 By Nasdaq GlobeNewswire

Prothena to Report First Quarter 2022 Financial Results on May 5th

28 Apr 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease

26 Apr 2022 07:30:00 By Nasdaq GlobeNewswire